Latest News & Features
Patents
On January 10 this year, the director of the USPTO issued new guidelines on enablement under 35 U.S.C §112. In recent years, the landscape of patent law in the United States has undergone a significant shift, with courts adopting a more stringent stance on the criteria of enablement and written description. 29 October 2024
Patents
In today's global marketplace, intellectual property (IP) rights are not merely legal tools but strategic assets that can significantly influence a product's lifecycle, from development to market. 29 October 2024
Patents
In the world of intellectual property, securing patents for innovative ideas rests heavily on the criteria of novelty, non-obviousness, and the inventive step. 29 October 2024
Patents
In an incredibly competitive and complex landscape, intellectual property is a critical asset for pharmaceutical and biotech companies. 29 October 2024
Patents
Patents are key to ensuring continued investment in pharma R&D.
What are the unique patent considerations for pharma/biotech patents and AI patents in Europe? 29 October 2024
Patents
In this session, Will James and Tim Harris will discuss their personal experiences litigating life sciences cases before the UPC. They will share their substantive and procedural insights, as well as strategic considerations and pitfalls to avoid. 29 October 2024
Patents
As part of a lifecycle IP strategy for a therapeutic product, it can be important to protect inventions arising during the clinical development of the product. 29 October 2024
Patents
Long-recognised, unwritten jurisdictional norms have seen questions of validity and infringement of registered IP rights reserved to the courts of the country of registration. 29 October 2024
Patents
Machine learning can be an invaluable tool in drug discovery for target identification, compound screening, and predictive modeling. The use of AI can accelerate drug discovery timelines, reduce costs and enhance therapeutic outcomes. 29 October 2024
Copyright
A court’s decision in favour of a software company is set to have a ripple effect on cases relating to fair use and artificial intelligence. Marisa Woutersen spoke to the winning counsel to find out more. 29 October 2024
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.